67184-0572 : Mirabgeorn 50 mg Oral Tablet, Film Coated, Extended Release


NDC: 67184-0572
Labeler: Qilu Pharmaceutical Co., Ltd.
Product Type: Human Prescription Drug
Drug Name:  Mirabgeorn
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: ANDA217989
Rev. Date: 


NDC Package Codes:

  • 67184-0572-1: 30 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (67184‑0572‑1)
  • 67184-0572-2: 90 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (67184‑0572‑2)

Active Ingredients:

  • Mirabegron

Dosage Strength:

  • 50 mg

Pharmaceutical Classes:

  • Adrenergic beta3-Agonists [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • beta3-Adrenergic Agonist [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67184-0572 QR Code

< Prev: 67184-0571Next: 67184-0573 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.